Occupational exposure to formaldehyde (50000) in kidney dialysis units was discussed. Formaldehyde is commonly used to sterilize kidney dialysis units. Epidemiological studies conducted by the National Institute for Occupational Safety and Health (NIOSH) were summarized. These have shown formaldehyde exposures up to 0.9 parts per million (ppm) and 1.9 milligrams per cubic meter occurring in dialysis units in hospitals in San Francisco, California, and Denver, Colorado, respectively. Employees at the San Francisco unit also reported experiencing cough, headache, and irritation of the eyes, nose, and throat. The physiological consequences of acute inhalational exposure to formaldehyde were described. These range from eye and upper respiratory tract irritation at exposures of 0.1 to 5ppm to pulmonary edema, pneumonitis, or death occurring at exposures of 50 to 100ppm. Formaldehyde induced dermatitis was discussed. Formaldehyde carcinogenicity was considered. Formaldehyde has been shown to induce a rare type of nasal cancer in Fischer-344-rats and B6C3F1-mice. It apparently causes the same type of cancer in Sprague-Dawley-rats. Based on these findings, NIOSH has recommended that formaldehyde be treated as a potential occupational carcinogen. Recommendations for minimizing exposure to formaldehyde in dialysis units were given. These included wearing appropriate protective clothing and equipment, ensuring that lines connecting portable and console units to the drain line be airtight, providing ventilation sufficient to achieve five air changes per hour in all rooms where formaldehyde is being used, and spending as little time as possible in rooms where dialysis units are being sterilized. NIOSH also recommends continually running water while sterilization is in progress in order to minimize formaldehyde vapors.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.